SCI-ENGI-MEDCO SOLUTIONS, INC
Biotech · Private
Small molecule therapeutics (AMP candidates) that activate apoptosis pathways to sensitize triple-negative breast cancer cells to chemotherapy while reducing anthracycline-related cardiotoxicity
- Grants
- $589K
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201620172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · AAAPT Technology for Improving Chemotherapy | $40,000 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Theranostics of Reduction of Cardiotoxicity Using Targeted Apoptosis Activation Technology | $274,452 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Theranostics of Reduction of Cardiotoxicity Using Targeted Apoptosis Activation Technology | $274,452 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3246 | DORIAN THERAPEUTICS, INC. | — | — |
| 3247 | TARGEAD SCIENCES, INC. | — | — |
| 3248 | SYMBIOTICA, INC. | — | — |
| 3249 | SCI-ENGI-MEDCO SOLUTIONS, INC | — | — |
| 3250 | Haplomics | — | — |
| 3251 | MBC PHARMA, INC. | — | — |
| 3252 | OM BHARTI LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.